KPV is an anti-inflammatory tripeptide. It is filed in this library under digestive & weight, a navigation topic rather than a statement of where it acts. As a regulatory matter it is not approved by the FDA for any use.
Regulatory status
KPV is not approved by the FDA for any use.
It is sold outside the approved-drug system, which means no regulator has reviewed its manufacturing, its purity or its effects.
On 30 July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend KPV for the 503A Bulks List, which would make it eligible for compounding.
A recommendation is not an approval.
On 30 October 2026 HHS published a notice of availability for a draft interim enforcement discretion policy on 503A compounding using certain peptide bulk drug substances (Federal Register, Docket HHS-OASH-2026-0496), open for written comment for two weeks.
HHS calls that policy interim and says FDA's future rulemakings may propose adding some or all of these peptides to the 503A bulks list.
A draft interim enforcement policy is not FDA approval.
Recommended for the 503A Bulks List on 30 July 2026. A recommendation is not an approval, and no rulemaking had begun as of October 2026.The evidence
3 sources on KPV published between 2007 and 2017, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.
Nearby
Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.
See the OPTML ScoreEducational reference only. This page explains what has been published about KPV. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides